Active efflux across the blood-brain barrier: Role of the solute carrier family

No abstract is available for this paper.

• Publication year

  2011

• Venue

  NeuroRx

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1602/neurorx.2.1.73PMID 15717059PMCID PMC539323
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bioerodible injectable poly(ortho ester) for tetracycline controlled delivery to periodontal pockets: Preliminary trial in humans

  2008cited by this paper
• Role of MRP4 and MRP5 in biology and chemotherapy

  2008cited by this paper
• Blood-Brain Barrier Genomics

  2007cited by this paper
• Vectorial transport of bile salts across MDCK cells expressing both rat Na+-taurocholate cotransporting polypeptide and rat bile salt export pump.

  2005cited by this paper
• Organic anion transporting polypeptides of the OATP/SLC21 family: phylogenetic classification as OATP/SLCO superfamily, new nomenclature and molecular/functional properties

  2004cited by this paper
• The MRP-related and BCRP/ABCG2 multidrug resistance proteins: biology, substrate specificity and regulation.

  2004cited by this paper
• ABC transporters and the blood-brain barrier.

  2004cited by this paper
• Impaired renal excretion of 6-hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl) benzothiazole (E3040) sulfate in breast cancer resistance protein (BCRP1/ABCG2) knockout mice.

  2004cited by this paper
• Plasma Membrane Localization of Multidrug Resistance-Associated Protein Homologs in Brain Capillary Endothelial Cells

  2004cited by this paper
• Localization of organic anion transporting polypeptide 3 (oatp3) in mouse brain parenchymal and capillary endothelial cells

  2004cited by this paper
• Involvement of multispecific organic anion transporter, Oatp14 (Slc21a14), in the transport of thyroxine across the blood-brain barrier.

  2004cited by this paper
• Mrp4 Confers Resistance to Topotecan and Protects the Brain from Chemotherapy

  2004cited by this paper
• How significant is the role of P-glycoprotein in drug absorption and brain uptake?

  2004cited by this paper
• Expression, up-regulation, and transport activity of the multidrug-resistance protein Abcg2 at the mouse blood-brain barrier.

  2004cited by this paper
• Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis.

  2004cited by this paper
• The SLC22 drug transporter family

  2004cited by this paper
• Carrier-mediated uptake of H2-receptor antagonists by the rat choroid plexus: involvement of rat organic anion transporter 3.

  2004cited by this paper
• Interactions between Hepatic Mrp4 and Sult2a as Revealed by the Constitutive Androstane Receptor and Mrp4 Knockout Mice*

  2004cited by this paper
• Functional expression of rat ABCG2 on the luminal side of brain capillaries and its enhancement by astrocyte‐derived soluble factor(s)

  2004cited by this paper
• The renal-specific transporter mediates facilitative transport of organic anions at the brush border membrane of mouse renal tubules.

  2004cited by this paper
• Mouse Reduced in Osteosclerosis Transporter Functions as an Organic Anion Transporter 3 and Is Localized at Abluminal Membrane of Blood-Brain Barrier

  2004cited by this paper
• Brain neurosteroids are 4th generation neuromessengers in the brain: cell biophysical analysis of steroid signal transduction.

  2003cited by this paper
• Organic anion transporter 3 (Slc22a8) is a dicarboxylate exchanger indirectly coupled to the Na+ gradient.

  2003cited by this paper
• Expression and Functional Involvement of Organic Anion Transporting Polypeptide Subtype 3 (Slc21a7) in Rat Choroid Plexus

  2003influential reference
• Functional Characterization of Rat Brain-specific Organic Anion Transporter (Oatp14) at the Blood-Brain Barrier

  2003influential reference
• Constitutive expression of various xenobiotic and endobiotic transporter mRNAs in the choroid plexus of rats.

  2003cited by this paper
• Expression of human organic anion transporters in the choroid plexus and their interactions with neurotransmitter metabolites.

  2003cited by this paper
• Impact of Drug Transporter Studies on Drug Discovery and Development

  2003cited by this paper
• Drug efflux transporters in the CNS.

  2003cited by this paper
• Structural and functional aspects of the blood-brain barrier.

  2003cited by this paper
• Contribution of Organic Anion Transporters to the Renal Uptake of Anionic Compounds and Nucleoside Derivatives in Rat

  2003cited by this paper
• The superfamily of organic anion transporting polypeptides.

  2003cited by this paper
• Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)

  2003cited by this paper
• Involvement of multidrug resistance associated protein 1 (Mrp1) in the efflux transport of 17beta estradiol-D-17beta-glucuronide (E217betaG) across the blood-brain barrier.

  2003cited by this paper
• Acetyl‐L‐carnitine permeability across the blood–brain barrier and involvement of carnitine transporter OCTN2

  2003cited by this paper
• Involvement of Multidrug Resistance Associated Protein 1 (Mrp1) in the Efflux Transport of 17β Estradiol-D-17β-Glucuronide (E217βG) Across the Blood-Brain Barrier

  2003influential reference
• Deficiency in the Organic Cation Transporters 1 and 2 (Oct1/Oct2 [Slc22a1/Slc22a2]) in Mice Abolishes Renal Secretion of Organic Cations

  2003cited by this paper
• Size-selective loosening of the blood-brain barrier in claudin-5–deficient mice

  2003cited by this paper
• Rat Organic Anion Transporter 3 (rOAT3) is Responsible for Brain-to-Blood Efflux of Homovanillic Acid at the Abluminal Membrane of Brain Capillary Endothelial Cells

  2003cited by this paper
• Contribution of Organic Anion Transporter 3 (Slc22a8) to the Elimination of p-Aminohippuric Acid and Benzylpenicillin across the Blood-Brain Barrier

  2003influential reference
• Molecular Identification of a Novel Carnitine Transporter Specific to Human Testis

  2002cited by this paper
• Expression and functional characterization of rat organic anion transporter 3 (rOat3) in the choroid plexus.

  2002influential reference
• Molecular aspects of renal anionic drug transport.

  2002cited by this paper
• Role of blood–brain barrier organic anion transporter 3 (OAT3) in the efflux of indoxyl sulfate, a uremic toxin: its involvement in neurotransmitter metabolite clearance from the brain

  2002cited by this paper
• Functional involvement of rat organic anion transporter 3 (rOat3; Slc22a8) in the renal uptake of organic anions.

  2002cited by this paper
• Confocal imaging of organic anion transport in intact rat choroid plexus.

  2002cited by this paper
• Localisation of breast cancer resistance protein in microvessel endothelium of human brain

  2002cited by this paper
• Effect of 17β-Estradiol-d-17β-Glucuronide on the Rat Organic Anion Transporting Polypeptide 2-Mediated Transport Differs Depending on Substrates

  2002cited by this paper
• Molecular identification of a renal urate–anion exchanger that regulates blood urate levels

  2002cited by this paper
• Effect of 17 beta-estradiol-D-17 beta-glucuronide on the rat organic anion transporting polypeptide 2-mediated transport differs depending on substrates.

  2002cited by this paper
• The influence of MDR1 polymorphisms on P-glycoprotein expression and function in humans.

  2002cited by this paper
• Impaired Organic Anion Transport in Kidney and Choroid Plexus of Organic Anion Transporter 3 (Oat3 (Slc22a8)) Knockout Mice*

  2002cited by this paper
• Identification of a novel human organic anion transporting polypeptide as a high affinity thyroxine transporter.

  2002cited by this paper
• Transcellular Transport of Organic Anions Across a Double-transfected Madin-Darby Canine Kidney II Cell Monolayer Expressing Both Human Organic Anion-transporting Polypeptide (OATP2/SLC21A6) and Multidrug Resistance-associated Protein 2 (MRP2/ABCC2)*

  2002cited by this paper
• Tissue expression, ontogeny, and inducibility of rat organic anion transporting polypeptide 4.

  2002cited by this paper
• Uptake and efflux of the peptidic delta-opioid receptor agonist.

  2001cited by this paper
• Ventricular Choline Transport

  2001cited by this paper
• Vectorial transport by double-transfected cells expressing the human uptake transporter SLC21A8 and the apical export pump ABCC2.

  2001cited by this paper
• Characterization of the Efflux Transport of 17β-Estradiol-d-17β-glucuronide from the Brain across the Blood-Brain Barrier

  2001influential reference
• Reduced Hepatic Uptake and Intestinal Excretion of Organic Cations in Mice with a Targeted Disruption of the Organic Cation Transporter 1 (Oct1 [Slc22a1]) Gene

  2001cited by this paper
• Localization of organic anion transporting polypeptide 4 (Oatp4) in rat liver and comparison of its substrate specificity with Oatp1, Oatp2 and Oatp3

  2001cited by this paper
• Characterization of the efflux transport of 17beta-estradiol-D-17beta-glucuronide from the brain across the blood-brain barrier.

  2001cited by this paper
• Functional relevance of carnitine transporter OCTN2 to brain distribution of l‐carnitine and acetyl‐l‐carnitine across the blood–brain barrier

  2001cited by this paper
• Impaired Activity of the Extraneuronal Monoamine Transporter System Known as Uptake-2 inOrct3/Slc22a3-Deficient Mice

  2001cited by this paper
• Comparative Studies on in Vitro Methods for Evaluating in Vivo Function of MDR1 P-Glycoprotein

  2001cited by this paper
• Neurotrophic and neuroprotective actions of estrogens and their therapeutic implications.

  2001cited by this paper
• Efflux transport systems for drugs at the blood-brain barrier and blood-cerebrospinal fluid barrier (Part 1).

  2001cited by this paper
• Molecular and physiological evidence for multifunctionality of carnitine/organic cation transporter OCTN2.

  2001cited by this paper
• Blood—Brain Barrier Genomics

  2001cited by this paper
• Uptake and efflux of the peptidic delta-opioid receptor agonist [D-penicillamine2,5]-enkephalin at the murine blood–brain barrier by in situ perfusion

  2001influential reference
• Drug transporters in the central nervous system: brain barriers and brain parenchyma considerations.

  2001cited by this paper
• The Choroid Plexuses and the Barriers Between the Blood and the Cerebrospinal Fluid

  2000cited by this paper
• Particle size analysis of concentrated phospholipid microemulsions: I. Total intensity light scattering

  2000cited by this paper
• Oatp2 mediates bidirectional organic solute transport: a role for intracellular glutathione.

  2000cited by this paper
• Conditionally immortalized brain capillary endothelial cell lines established from a transgenic mouse harboring temperature-sensitive simian virus 40 large T-antigen gene

  2000cited by this paper
• Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan.

  2000cited by this paper
• Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo.

  2000cited by this paper
• Blood—Brain Barrier Is Involved in the Efflux Transport of a Neuroactive Steroid, Dehydroepiandrosterone Sulfate, via Organic Anion Transporting Polypeptide 2

  2000cited by this paper
• Molecular and Functional Characterization of Organic Cation/Carnitine Transporter Family in Mice*

  2000cited by this paper
• Organic anion-transporting polypeptides mediate transport of opioid peptides across blood-brain barrier.

  2000influential reference
• Brain-to-blood efflux transport of estrone-3-sulfate at the blood-brain barrier in rats.

  2000influential reference
• Xenobiotic transport across isolated brain microvessels studied by confocal microscopy.

  2000influential reference
• Expression, transport properties, and chromosomal location of organic anion transporter subtype 3.

  2000cited by this paper
• P-Glycoprotein, a gatekeeper in the blood-brain barrier.

  1999cited by this paper
• Decreased tissue distribution of L-carnitine in juvenile visceral steatosis mice.

  1999cited by this paper
• Localization of the Organic Anion Transporting Polypeptide 2 (Oatp2) in Capillary Endothelium and Choroid Plexus Epithelium of Rat Brain

  1999cited by this paper
• Polyspecific organic anion transporting polypeptides mediate hepatic uptake of amphipathic type II organic cations.

  1999cited by this paper
• Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter

  1999cited by this paper
• Molecular Pharmacology of Organic Cation Transporters in Kidney

  1999cited by this paper
• OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine.

  1999cited by this paper
• Molecular Cloning and Characterization of a New Multispecific Organic Anion Transporter from Rat Brain*

  1999influential reference
• Identification of a Novel Gene Family Encoding Human Liver-specific Organic Anion Transporter LST-1*

  1999cited by this paper
• Localization and function of the organic anion-transporting polypeptide Oatp2 in rat liver.

  1999cited by this paper
• Efflux of taurocholic acid across the blood-brain barrier: interaction with cyclic peptides.

  1998influential reference
• Molecular Characterization and Tissue Distribution of a New Organic Anion Transporter Subtype (oatp3) That Transports Thyroid Hormones and Taurocholate and Comparison with oatp2*

  1998influential reference
• Excretion of GSSG and Glutathione Conjugates Mediated by MRP1 and CM0AT/MRP2

  1998cited by this paper
• Molecular cloning and characterization of high-affinity carnitine transporter from rat intestine.

  1998cited by this paper
• Molecular and Functional Identification of Sodium Ion-dependent, High Affinity Human Carnitine Transporter OCTN2*

  1998cited by this paper
• Molecular aspects of hepatobiliary transport.

  1997cited by this paper
• Kidney‐specific expression of a novel mouse organic cation transporter‐like protein

  1997cited by this paper

• Intracerebral Distribution of Drugs with Diverse Blood-brain Barrier Transport Characteristics: In vivo Analysis using Brain Microdialysis in Cynomolgus Monkeys.

  2025cites this paper
• Breaking Barriers in Huntington’s Disease Therapy: Focused Ultrasound for Targeted Drug Delivery

  2025cites this paper
• Genotype-driven sensitivity of mice to tick-borne encephalitis virus correlates with differential host responses in peripheral macrophages and brain

  2025cites this paper
• Accumulation, biotransformation and time-dependent transcriptomic responses to PSTs in scallop kidneys.

  2025cites this paper
• The canine blood-brain barrier in health and disease: focus on brain protection

  2025cites this paper
• Advances in probe crossing the blood–brain barrier strategies and fluorescent imaging for brain dynamics

  2025cites this paper
• Effects of co‐administration of lamotrigine on valproate transfer across the placenta and its brain entry in developing Genetic Absence Epilepsy Rats from Strasbourg (GAERS)

  2024cites this paper
• Multiple Instance Learning-Based Prediction of Blood-Brain Barrier Opening Outcomes Induced by Focused Ultrasound

  2024cites this paper
• Circulating low-molecular-weight (poly)phenol metabolites in the brain: unveiling in vitro and in vivo blood–brain barrier transport

  2024cites this paper
• Advancing Central Nervous System Drug Delivery with Microtubule-Dependent Transcytosis of Novel Aqueous Compounds

  2024cites this paper
• Experimental Models of In Vitro Blood–Brain Barrier for CNS Drug Delivery: An Evolutionary Perspective

  2023cites this paper
• Prediction of nanobubble-assisted focused ultrasound-induced blood-brain barrier opening with machine learning

  2023cites this paper
• Effects of subchronic exposure of perfluorooctane sulfonate on cognitive function of mice and its mechanism.

  2023cites this paper
• Contribution of Direct Cerebral Vascular Transport in Brain Substance Clearance

  2023cites this paper
• Penetration of Organophosphate Triesters and Diesters across the Blood-Cerebrospinal Fluid Barrier: Efficiencies, Impact Factors, and Mechanisms.

  2022cites this paper
• Genetics of common cerebral small vessel disease

  2022cites this paper
• Current Chemical, Biological, and Physiological Views in the Development of Successful Brain-Targeted Pharmaceutics

  2022cites this paper
• Fate and biological impact of persistent luminescence nanoparticles after injection in mice: a one-year follow-up.

  2022cites this paper
• “Focused Ultrasound-mediated Drug Delivery in Humans – a Path Towards Translation in Neurodegenerative Diseases”

  2022cites this paper
• Xenobiotic Transport and Metabolism in the Human Brain.

  2021cites this paper
• Assessment of Brain-To-Blood Drug Distribution Using Liquid Chromatography.

  2021cites this paper
• CNS pharmacology of NKCC1 inhibitors.

  2021cites this paper
• Clozapine affects the pharmacokinetics of risperidone and inhibits its metabolism and P-glycoprotein-mediated transport in vivo and in vitro: A safety attention to antipsychotic polypharmacy with clozapine and risperidone.

  2021cites this paper
• Disease-Induced Modulation of Drug Transporters at the Blood–Brain Barrier Level

  2021cites this paper
• Role of Elevated SFLT‐1 on the Regulation of Placental Transporters in Women With Pre‐Eclampsia

  2020cites this paper
• Dynamic Disequilibrium of Macromolecular Transport as Possible Mechanism for Hydrocephalus Associated With Long-Term Spaceflight.

  2020cites this paper
• Nanotherapeutics in glioma management: Advances and future perspectives

  2020cites this paper
• P-glycoprotein Substrate Assessment in Drug Discovery: Application of Modeling to Bridge Differential Protein Expression Across In Vitro Tools.

  2020cites this paper
• PET Imaging of Microglia Activation and Infection in Neuropsychiatric Disorders with Potential Infectious Origin

  2020cites this paper
• The search for brain-permeant NKCC1 inhibitors for the treatment of seizures: Pharmacokinetic-pharmacodynamic modelling of NKCC1 inhibition by azosemide, torasemide, and bumetanide in mouse brain.

  2020cites this paper
• Low Molecular Weight (poly)Phenol Metabolites Across the Blood-Brain Barrier: The Underexplored Journey

  2020cites this paper
• Correlation of MCT1 and ABCC2 gene polymorphisms with valproic acid resistance in patients with epilepsy on valproic acid monotherapy.

  2019cites this paper
• Safety and efficacy of focused ultrasound induced blood-brain barrier opening, an integrative review of animal and human studies.

  2019cites this paper
• In vitro and in vivo models of BBB to evaluate brain targeting drug delivery

  2019cites this paper
• Organic Anion Transporting Polypeptides: Emerging Roles in Cancer Pharmacology

  2019cites this paper
• ABC Transporters at the Blood–Brain Interfaces, Their Study Models, and Drug Delivery Implications in Gliomas

  2019cites this paper
• Membrane transporters in traumatic brain injury: Pathological, pharmacotherapeutic, and developmental implications.

  2019cites this paper
• Large-Scale Quantitative Comparison of Plasma Transmembrane Proteins between Two Human Blood-Brain Barrier Model Cell Lines, hCMEC/D3 and HBMEC/ciβ.

  2019cites this paper
• Prediction of Drug Permeability Using In Vitro Blood–Brain Barrier Models with Human Induced Pluripotent Stem Cell-Derived Brain Microvascular Endothelial Cells

  2019cites this paper
• Nanoparticle-mediated drug delivery: blood-brain barrier as the main obstacle to treat infectious diseases in CNS.

  2019cites this paper
• Tuning Properties for Blood-Brain Barrier (BBB) Permeation: A Statistics-Based Analysis.

  2019cites this paper
• Treatment of HIV associated neurocognitive disorders

  2018cites this paper
• Recent advances in drug and nutrient transport across the blood-retinal barrier

  2018cites this paper
• Regulation of brain drug metabolizing enzymes and transporters by nuclear receptors

  2018cites this paper
• Pericyte Influence on Drug Delivery Across the Blood-Brain Barrier : Implications for Therapy of Neurodegenerative Diseases

  2018influential citation
• Elimination of substances from the brain parenchyma: efflux via perivascular pathways and via the blood–brain barrier

  2018cites this paper
• EXPLORATION OF METFORMIN EFFECT OVER OXALIPLATIN ANTINEOPLASIC PROPERTIES IN MKN45, KATOIII AND HS746T GASTRIC CANCER CELL LINES IN VITRO AND OVER OXALIPLATIN INDUCED RAT PAINFUL SENSORY NEUROPATHY IN VIVO.

  2018cites this paper
• Efflux proteins at the blood–brain barrier: review and bioinformatics analysis

  2018cites this paper
• Design and synthesis of new potent N,N-bis(arylalkyl)piperazine derivatives as multidrug resistance (MDR) reversing agents.

  2018cites this paper
• Steroid Transport, Local Synthesis, and Signaling within the Brain: Roles in Neurogenesis, Neuroprotection, and Sexual Behaviors

  2018cites this paper
• Developing a novel strategy to treat glioblastoma : improving brain bioavailability of sorafenib with a synthetic flavonoid dimer to inhibit drug efflux in blood brain barrier

  2018cites this paper
• Evaluation of Organic Anion Transporter 1A2-knock-in Mice as a Model of Human Blood-brain Barrier

  2018cites this paper
• Blood-Brain Barrier Mechanisms of Edema Formation

  2017cites this paper
• The sensitivity of glioma cells to pyropheophorbide‐αmethyl ester‐mediated photodynamic therapy is enhanced by inhibiting ABCG2

  2017cites this paper
• Investigation of the Importance of Multidrug Resistance-Associated Protein 4 (Mrp4/Abcc4) in the Active Efflux of Anionic Drugs Across the Blood-Brain Barrier.

  2017cites this paper
• Microdialysis: the Key to Physiologically Based Model Prediction of Human CNS Target Site Concentrations

  2017cites this paper
• Regulation of Drug Transporters by Inflammation

  2017cites this paper
• Large-scale identification of human cerebrovascular proteins: Inter-tissue and intracerebral vascular protein diversity

  2017cites this paper
• Probenecid, an organic anion transporter 1 and 3 inhibitor, increases plasma and brain exposure of N-acetylcysteine

  2017cites this paper
• Functional Expression of P-glycoprotein and Organic Anion Transporting Polypeptides at the Blood-Brain Barrier: Understanding Transport Mechanisms for Improved CNS Drug Delivery?

  2017cites this paper
• N-alkanol-N-cyclohexanol amine aryl esters: Multidrug resistance (MDR) reversing agents with high potency and efficacy.

  2017cites this paper
• Multiple blood‐brain barrier transport mechanisms limit bumetanide accumulation, and therapeutic potential, in the mammalian brain

  2017influential citation
• Integrated Lead Optimization: Translational Models as We Advance Toward the Clinic

  2017cites this paper
• Phytochemical mediated modulation of breast cancer resistance protein at the blood brain barrier and blood cerebrospinal fluid barrier

  2016cites this paper
• Review of Scientific Evidence of Medicinal Convoy Plants in Traditional Persian Medicine

  2016cites this paper
• Effect of Disease Pathologies on Transporter Expression and Function

  2016cites this paper
• Development of a Support Vector Machine-Based System to Predict Whether a Compound Is a Substrate of a Given Drug Transporter Using Its Chemical Structure.

  2016cites this paper
• Noninvasive Evaluation of Cellular Proliferative Activity in Brain Neurogenic Regions in Rats under Depression and Treatment by Enhanced [18F]FLT-PET Imaging

  2016cites this paper
• Cell Culture Models for Drug Transport Studies

  2016cites this paper
• The organic anion transport inhibitor probenecid increases brain concentrations of the NKCC1 inhibitor bumetanide.

  2015cites this paper
• Brain delivery of insulin boosted by intranasal coadministration with cell-penetrating peptides.

  2015cites this paper
• Study of the antiepileptic drugs transport through the immature blood-brain barrier

  2015cites this paper
• Targeting transporters: promoting blood-brain barrier repair in response to oxidative stress injury.

  2015cites this paper
• Quantitative Aspects of Nanodelivery Across the Blood-Brain Barrier Exemplified with the Opioid Peptide

  2015cites this paper
• The neurovascular unit

  2015cites this paper
• Development of Lipid Based Nanoparticulate Drug Delivery Systems and Drug Carrier Complexes for Delivery to Brain

  2015cites this paper
• Blood-brain barrier permeability mechanisms in view of quantitative structure-activity relationships (QSAR).

  2015cites this paper
• Prenatal exposure to common environmental factors affects brain lipids and increases risk of developing autism spectrum disorders

  2015influential citation
• Uptake Transport at the BBB—Examples and SAR

  2015cites this paper
• The effect of organic anion transporter 3 inhibitor probenecid on bumetanide levels in the brain: an integrated in vivo microdialysis study in the rat

  2015influential citation
• PBPK Modeling Approach for Predictions of Human CNS Drug Brain Distribution

  2015cites this paper
• Dynamic Control of Neural Reproductive Centers by Endothelial Cells

  2015cites this paper
• Blood Brain Barrier: A Challenge for Effectual Therapy of Brain Tumors

  2015cites this paper
• Advances in Neurotherapeutic Delivery Technologies

  2015cites this paper
• Central Nervous System Penetration of Antiretroviral Drugs: Pharmacokinetic, Pharmacodynamic and Pharmacogenomic Considerations

  2015cites this paper
• Quantitative Aspects of Nanodelivery Across the Blood-Brain Barrier : Exemplified with the Opioid Peptide DAMGO

  2015cites this paper
• Transport Mechanisms of Neurotherapeutics across the Blood-Brain Barrier eBooks

  2015cites this paper
• Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.

  2015cites this paper
• Functional Characterization of Carrier-Mediated Transport of Pravastatin across the Blood-Retinal Barrier in Rats

  2015cites this paper
• A proposed role for efflux transporters in the pathogenesis of hydrocephalus

  2014cites this paper
• PKPD Aspects of Brain Drug Delivery in a Translational Perspective

  2014cites this paper
• Post-Acute Brain Injury Urinary Signature: A New Resource for Molecular Diagnostics

  2014cites this paper
• Virus-Induced Transcriptional Changes in the Brain Include the Differential Expression of Genes Associated with Interferon, Apoptosis, Interleukin 17 Receptor A, and Glutamate Signaling as Well as Flavivirus-Specific Upregulation of tRNA Synthetases

  2014cites this paper
• Multidrug resistance (MDR) reversers: High activity and efficacy in a series of asymmetrical N,N-bis(alkanol)amine aryl esters.

  2014cites this paper
• Multidrug resistance in cancer or inefficacy of neuroactive agents: innovative strategies to inhibit or circumvent the active efflux transporters selectively.

  2014cites this paper
• Barrier mechanisms in the Drosophila blood-brain barrier

  2014cites this paper
• Handbook of metallonutraceuticals

  2014cites this paper
• Acetyl-L-Carnitine Prevents Methamphetamine-Induced Structural Damage on Endothelial Cells via ILK-Related MMP-9 Activity

  2014cites this paper
• Transporters at CNS barrier sites: obstacles or opportunities for drug delivery?

  2014cites this paper
• PET Imaging of Microglia Activation in Neuropsychiatric Disorders with Potential Infectious Origin

  2014cites this paper